Eli Lilly and Co (LLY)
747.82
-2.10
(-0.28%)
USD |
NYSE |
Nov 22, 16:00
747.05
-0.77
(-0.10%)
After-Hours: 20:00
Eli Lilly Free Cash Flow (Quarterly): -458.90M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -458.90M |
| June 30, 2024 | 63.40M |
| March 31, 2024 | 83.20M |
| December 31, 2023 | -1.963B |
| September 30, 2023 | -1.812B |
| June 30, 2023 | -204.40M |
| March 31, 2023 | 827.10M |
| December 31, 2022 | 1.024B |
| September 30, 2022 | 1.565B |
| June 30, 2022 | 369.70M |
| March 31, 2022 | 1.642B |
| December 31, 2021 | 1.762B |
| September 30, 2021 | 1.176B |
| June 30, 2021 | 1.244B |
| March 31, 2021 | 1.205B |
| December 31, 2020 | 995.70M |
| September 30, 2020 | 1.392B |
| June 30, 2020 | 1.972B |
| March 31, 2020 | 111.10M |
| December 31, 2019 | 1.637B |
| September 30, 2019 | 1.169B |
| June 30, 2019 | 766.20M |
| March 31, 2019 | -89.30M |
| December 31, 2018 | 825.00M |
| September 30, 2018 | 1.822B |
| Date | Value |
|---|---|
| June 30, 2018 | -340.70M |
| March 31, 2018 | 200.00M |
| December 31, 2017 | 1.25B |
| September 30, 2017 | 1.433B |
| June 30, 2017 | 1.430B |
| March 31, 2017 | -660.90M |
| December 31, 2016 | 1.542B |
| September 30, 2016 | 1.434B |
| June 30, 2016 | 1.156B |
| March 31, 2016 | -373.40M |
| December 31, 2015 | 441.90M |
| September 30, 2015 | 781.20M |
| June 30, 2015 | 588.70M |
| March 31, 2015 | -473.40M |
| December 31, 2014 | 673.80M |
| September 30, 2014 | 1.349B |
| June 30, 2014 | 799.00M |
| March 31, 2014 | 70.30M |
| December 31, 2013 | 1.182B |
| September 30, 2013 | 1.738B |
| June 30, 2013 | 1.501B |
| March 31, 2013 | 221.50M |
| December 31, 2012 | 1.152B |
| September 30, 2012 | 1.328B |
| June 30, 2012 | 1.092B |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.963B
Minimum
Dec 2023
1.972B
Maximum
Jun 2020
631.56M
Average
1.010B
Median
Free Cash Flow (Quarterly) Benchmarks
| Amgen Inc | 3.314B |
| Biogen Inc | 805.60M |
| Johnson & Johnson | 5.714B |
| Viking Therapeutics Inc | -21.96M |
| Moderna Inc | -1.717B |